Abstract:BACKGROUND: Every existing prosthetic valve, either mechanical valve prosthesis or biovalve, has its inherent defects that are determined by its material itself and can not be avoided no matter what manufacturing technique is used. Fortunately, the concept of tissue engineering heart valve (TEHV) provides a new direction for the solution of the above-mentioned dilemma. OBJECTIVE: To analyze which kind of cells is the more suitable seeding cells for tissue engineering heart valves, well-differentiated vascular endothelial cells or bone marrow mesenchymal stem cells (MSCs), by comparing the obtaining methods of the two, as well as their in vitro proliferation abilities and their growth potentials on acellular matrixes. DESIGN, TIME AND SETTING: A single sample observation was completed in the Animal Experiment Base of Shanghai Chest Hospital from June to September in 2008. MATERIALS: Acellular matrixes were obtained by digesting aortic valves of pigs with Trypsin-EDTA, Triton X-100, DNase and RNase. Seeding cells were obtained from the great saphenous veins, the lateral femoral arteries and the ribs marrows of a male hybrid dog of two years old, weighing 12 kg. METHODS: Trypsin digestion was adopted to collect endothelial cells which, together with the bone marrow cells, were cultured separately. The endothelial cells and MSCs were harvested with adherence method. Then, the MSCs were induced into endothelial cells using endothelial cell growth factors, and the cell growth curve was drawn simultaneously. After that, MSCs were stained with the anti-VIII factor antibody and the anti-vascular endothelial growth factor (anti-VEGF) antibody, and then were observed under the fluorescence microscope. After 3 days of culture on acellular valves, seeding cells were observed under the scanning electron microscope. MAIN OUTCOME MEASURES: Circled digit oneThe wound healing of the experiment dog; Circled digit twoThe culture and proliferation of cells; Circled digit threeThe phenotype analyses and morphology observation of MSCs. RESULTS: Compared with well-differentiated vascular endothelial cells, MSCs showed a much greater expanding ability in vitro. The doubling time of MSCs was 30 hours according to the cell growth curve, which is a well contrast to the flat one of the mature endothelial cells. Moreover, MSCs showed positive fluorescence staining after being stained with fluorescent anti-factor VBl antibody and fluorescent anti-VEGF antibody. Under scanning electron microscope, adherent stellate cells could be seen scattering on the culturing acellular valves of MSCs. CONCLUSION: MSCs not only have a strong ability of in vitro proliferation, but also can be induced into endothelial cells by endothelial cell growth factors. What's more, they can grow on and adhere to acellular valves. All of these show that MSCs are the ideal seeding cells for TEHV preparation.

[Subcutaneous Implantation of Tissue-Engineered Heart Valve Leaflets in Nude Mice].

In Vitro Experience with Tissue-Engineered Heart Valve Leaflets

A Novel and Knotless Technique for Heterotopic Cardiac Transplantation in Mice

Enhancement of Viability of Fat Grafts in Nude Mice by Endothelial Progenitor Cells

In vivo functional assessment of a novel degradable metal and elastomeric scaffold-based tissue engineered heart valve

Decellularized Xenogenic Valve Scaffolds Coated with Biodegradable Polymer for Heart Valve Tissue Engineering

In vitro construction of tissue-engineered cardiac valve on collagen-chitosan scaffold

Preparation of Heart Valve Scaffold and Cell Seeding

Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): preparation of a prototype model

Application of endothelial cells cultured from human bone marrow stromal cells in tissue-engineered heart valve

A Novel Detergent-Based Decellularization Combined with Carbodiimide Crosslinking for Improving Anti-Calcification of Bioprosthetic Heart Valve.

Ideal seeding cells for tissue engineering heart valves

Role of TGF-β1 Signaling in Heart Valve Calcification Induced by Abnormal Mechanical Stimulation in a Tissue Engineering Model

Ulvan mediated VE cadherin antibody and REDV peptide co-modification to improve endothelialization potential of bioprosthetic heart valves

Optimization of Enzymatic and Chemical Decellularization of Native Porcine Heart Valves for the Generation of Decellularized Xenografts

Melt-electrowriting-enabled anisotropic scaffolds loaded with valve interstitial cells for heart valve tissue Engineering

Biomatrix/polymer composite material for heart valve tissue engineering

Induction of Bone Marrow CD34+ Cells and Endothelialization of Polytetrafluoroethylene Prostheses.

Early Feasibility Study of a Hybrid Tissue-Engineered Mitral Valve in an Ovine Model

The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model

Study on decellularized porcine aortic valve/poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) hybrid heart valve in sheep model.